ライフサイエンスコーパス: mean weight

1 ts and an effective way to reduce population mean weight.

2 Of the hamsters with small tumors (mean weight 0.43 +/- 0.25 g), 87.5% were disease-free 7

3 When hamsters with larger tumors (mean weight 0.66 +/- 0.11 g) were treated with 64Cu- or

4 Based on the increase in snake mackerel (mean weight 0.8 kg) and lancetfish catches, the discards

5 allograft recipients weighing < or = 15 kg, mean weight 11.2 +/- 2.6 kg.

6 nor age less than 5 years vs. 6 to 10 years (mean weight, 16.4 vs. 32.7 kg) revealed no differences i

7 Domestic Yorkshire pigs (n = 4; mean weight, 23.4 kg) were anesthetized, and their liver

8 ult anesthesized and paralyzed mongrel dogs (mean weight 24.3+/- 4.4 kg).

9 Ten healthy swine (mean weight, 24.6 kg) with saline lavage-induced acute l

10 Six anesthetized, paralyzed mongrel dogs (mean weight, 24.7+/-3.8 kg).

11 F0145 (10 to 40 mg) in 13 closed chest dogs (mean weight 25.6 kg).

12 Nineteen healthy swine (mean weight 28.9 kg) with saline lavage-induced acute lu

13 wenty-eight infants (mean age 1 +/- .6 days, mean weight 3.6 +/- .6 kg) with critical aortic stenosis

14 Thirty-two piglets (mean weight, 30 [range, 24-35] kg).

15 Thirty-two mixed-breed piglets (mean weight, 30 kg).

16 placed in the livers of seven domestic pigs (mean weight, 30.0 kg +/- 14.0 [SD]) as tumor-mimicking l

17 Twenty adult female sheep (mean weight, 33.1+/-0.9 kg).

18 was retrospectively validated in six swine (mean weight, 37.3 kg +/- 7.5 [standard deviation]) betwe

19 Twelve healthy growing swine (mean weight, 38.4 kg; weight range, 30.3-47.0 kg) were e

20 balance in 12 boys and 13 girls aged 9-14 y (mean weight: 42 kg) maintained on relatively high calciu

21 embolization were tested in three farm pigs (mean weight 43 kg +/- 2 [standard deviation]) under real

22 ablation was performed in 18 domestic pigs (mean weight, 45 kg) by using a 17-gauge (1.5-mm-diameter

23 Thirteen female domestic pigs (mean weight, 45 kg) were used.

24 thoracotomy in eight female domestic swine (mean weight, 55 kg) by using a microwave ablation system

25 ositive PTH gradient, a parathyroid adenoma (mean weight 636 +/- 196 mg) was resected from a location

26 for 7 minutes at 60 W in six porcine livers (mean weight, 68.2 kg) by using single (n = 7) or dual 2.

27 The non-commercial species lancetfish (mean weight 7 kg) has now surpassed the target species,

28 Thirteen female domestic swine (mean weight, 70 kg) were used for the study as approved

29 Mean weight (78 +/- 19 vs 67 +/- 16 kg), body mass index

30 dard deviation]; age range, 52.8-67.4 years; mean weight, 78.9 kg +/- 18.3; 12 men, 10 women) gave in

31 e, 56.1 years +/- 15.8 [standard deviation]; mean weight, 79.1 kg +/- 14.8) who underwent routine CT

32 age +/- SD, 37.2 +/- 15.6 y; range, 28-65 y; mean weight, 79.2 +/- 21.0 kg; range, 64-115 kg) were in

33 om donors less than or equal to 10 kg (n=11; mean weight=8.85 kg), but there was a higher incidence o

34 ino; high viral load; advanced fibrosis; and mean weight, 82 kg) were 28.4%, 24.3%, 20.6%, and 21.4%

35 ected parathyroid glands were hypercellular (mean weight = 895 +/- 86 mg).

36 Two groups of 5 piglets (mean weight 9.6+/-1.3 kg) with a cranial window over par

37 g 9 months, 45 patients (mean age, 44 years; mean weight, 92.5 kg) prospectively underwent both nonen

38 omen (mean age, 28.1 years; Hispanic, 81.6%; mean weight above prepregnancy weight, 7.8 kg; mean mont

39 is of covariance methods were used to obtain mean weight and body fat changes adjusted for potential

40 4) and control (n = 1185) groups had similar mean weights and BMIs.

41 recipient sex, race, cause of renal failure, mean weight, and follow-up duration (37.8 vs. 37.5 month

42 loss during initiation was 7.2 kg (SD, 3.1); mean weight at randomization was 103.6 kg (SD, 20.4).

43 Mean weight at the time of transplantation was 3.8+/-1.0

44 group lost almost 3 kg over 12 months (crude mean weight: baseline 104.38 kg [SD 21.11; n=279], 6 mon

45 Mean weight/body mass index unit loss after revision of

46 Mean weight change at 12 months was -5.06 kg (SE 0.31) f

47 In the entire study population, mean weight change at 12 months was 2.43 kg with the sup

48 st weight; after 6 months, the least-squares mean weight change for those taking paliperidone palmita

49 Mean weight change from baseline in the intervention gro

50 Mean weight change in the control group at the same time

51 During the VLCD/LCD period, the pooled mean weight change was -12.3 kg (median duration: 8 wk;

52 Mean weight changes among children who achieved nonoverw

53 At 1 year, mean weight changes in the groups were -3.26 kg (brief i

54 Mean weight changes were small in the 25-, 50-, and 75-m

55 rTMS versus sham treatment for AVH yielded a mean weighted effect size of .44.

56 with a frequency of 1 Hz yielded a moderate mean weighted effect size of .63, indicating superiority

57 patients with medication-resistant AVH, the mean weighted effect size was .45.

58 No significant mean weighted effect size was found for the severity of

59 a meta-analysis to establish and compare the mean weighted effect sizes (WESs) of the 4 most commonly

60 Standardized mean weighted effect sizes were computed; a qualitative

61 The overall summary mean weighted estimates of sensitivity and specificity w

62 Mean weighted follow-up duration was 7.4 years (in 13 st

63 n the autistic cases differed from normative mean weight for age by a mean of 17.6% (95% CI, 10.2%-25

64 88, 95% CI 0.71-1.08), and the difference in mean weight-for-age Z score was 0.09 (95% CI -0.04 to 0.

65 d (1035 vs. 835 cells/mm(3); P=.043), higher mean weight-for-age Z scores (-0.15 vs. -0.84; P=.01), a

66 Mean weight-for-age z scores were marginally higher in t

67 19 prepubertal girls aged 6.0-10.1 y with a mean weight-for-height of 108% of ideal.

68 the course of treatment (P < 0.003), higher mean weight-for-height z score at discharge (P < 0.008),

69 Infants in the RP group also had lower mean weight-for-length percentiles at 1 year than infant

70 , male 5alphaR1-KO mice demonstrated greater mean weight gain (21.6 +/- 1.4 vs 16.2 +/- 2.4 g), hyper

71 The mean weight gain among discharged children was 2.7 +/- 1

72 ng women with BMI<30 prior to the pregnancy, mean weight gain decreased with increasing months of lac

73 near regression models were used to estimate mean weight gain in 14 y of follow-up according to each

74 Age-adjusted models showed a lower mean weight gain in participants who increased their caf

75 Mean weight gain in the LT patients was 1.0 kg versus 2.

76 0.01), whereas among obese women (BMI>/=30), mean weight gain increased with increasing duration of l

77 group was 1.13 kg (SD 4.12), compared with a mean weight gain of 0.51 kg (3.65) in the control group,

78 The differences in postpartum mean weight gain persisted over the 8-year study period.

79 The mean weight gain was higher in the prandial group than i

80 Mean weight gain was higher with deflation than inflatio

81 Overall, lactation was not associated with mean weight gain.

82 ong those with high acute insulin secretion, mean weight-gain rate was still rather low in those with

83 For these 40 patients, the mean weight gained at year 1 did not regress by the end

84 smoking to quit-smoking in a given year had mean weight gains of 2.95 kg/year (3.61%) in men and 3.0

85 year were 5.7, 12.0, and 2.3; and respective mean weight gains were 4.7 kg, 5.7 kg, and 1.9 kg.

86 h quetiapine-ER (p=0.0008), with an adjusted mean weight group difference at week 12 of 3.33 kg (SD 7

87 At 3 years after the procedure, the mean weight had decreased by 27% (95% confidence interva

88 Mean weights in inferior retina were 9% (M), 50% (S), an

89 omerizations per rod per second (Rh*/rod/s), mean weights in superior retina were 52% (M), 2% (S), an

90 The mean weight increase was 5.5 kg; half was attributable t

91 Relative to placebo, mean weight increased by 1.2 kg with 2 g EPA (95% CI, 0

92 e 1-year follow-up (2006-2007 to 2007-2008), mean weight increased by 1.72 kg (standard deviation, 4.

93 years of follow-up (1996-1997 to 1999-2000), mean weight increased by 2.1 kg (standard deviation (SD)

94 Mean weight increases of 2.2 kg. and 0.9 kg occurred in

95 Cronbach alpha values for mean weighted internal consistency were 0.83 and 0.89 fo

96 mphysema in each lobe showed good agreement (mean weighted kappa = 0.70) and correlated with findings

97 high level of intrarater reliability, with a mean weighted kappa value of 0.81 (95% confidence interv

98 The mean weighted kappa values in 2006 were 0.36 (range 0.21

99 us, preplus, or normal) among the 6 experts (mean weighted kappa, 0.27; range, 0.06-0.63), but good c

100 The mean weighted LDL-C gene score of the WHII participants

101 ative UK patients had a significantly higher mean weighted LDL-C score (1.0 [SD 0.21]) than did WHII

102 After 3 wk, the mean weight loss (5.12 +/- 1.83 kg) was induced in all d

103 body mass index decreased post-operatively (mean weight loss 59 +/- 15 kg, pre-operative body mass i

104 t to lifestyle intervention, lead to greater mean weight loss and an increased likelihood of achievin

105 terventionists, were associated with greater mean weight loss and likelihood of patients losing 5% or

106 By study exit, mean weight loss and mean HbA1c% reduction were 15.4 +/-

107 Mean weight loss at baseline was 18% (n = 518).

108 ications to lifestyle intervention increases mean weight loss by 2.5 to 8.9 kg compared with placebo.

109 At week 64, the mean weight loss compared with baseline was -10.1 kg (95

110 Although mean weight loss did not reach the targeted 5%, the mean

111 ing tube placement in 35 patients (85%), the mean weight loss during chemoradiotherapy was 13.3% of i

112 Mean weight loss during initiation was 7.2 kg (SD, 3.1);

113 Mean weight loss for diet + exercise participants was 10

114 ta-analysis of orlistat, the estimate of the mean weight loss for orlistat-treated patients was 2.89

115 The mean weight loss for topiramate-treated subjects who com

116 ing data, RYGB participants had the greatest mean weight loss from baseline (27.0%; 95% CI, 30.8-23.3

117 At 24 months, mean weight loss in the intervention and control groups

118 Mean weight loss in the intervention group was 1.13 kg (

119 et, without exercise training, resulted in a mean weight loss of 13 kg and a body mass index (in kg/m

120 Treatment was associated with mean weight loss of 5.0 kg (95% CI 3.5,6.5 kg), mean HbA

121 The women in the intervention group had a mean weight loss of 8.0% (7.8 kg), as compared with 1.6%

122 The zonisamide group (n = 19) had a mean weight loss of 9.2 kg (1.7 kg) (9.4% loss) at week

123 and 50.1 kg/m2 to 211 lbs and 34 kg/m2 for a mean weight loss of 97 lbs and mean excess weight loss o

124 posed to 4% acetic acid solution exhibited a mean weight loss rate (WLR) for the control group (Dicor

125 dults, the use of SBWI resulted in a greater mean weight loss than STEP over 18 months.

126 After the 16-wk LED-only period, the mean weight loss was -15.0 kg (95% CI: -16.6, -13.4 kg),

127 In intention-to-treat analyses, the mean weight loss was 4.4 kg in the intervention group an

128 At 48 weeks, estimated mean weight loss was 5.7 kg (95% CI, 4.3 to 7.0 kg) in t

129 At 12 months, mean weight loss was 6.0% of initial weight in the inter

130 t analysis with baseline value substitution, mean weight loss was 7.4 kg (95% confidence interval [CI

131 During the initial 6-month program, mean weight loss was 8.5 kg.

132 Mean weight loss was significantly (P < .001) greater in

133 gnificantly by intervention group (estimated mean weight loss, 3.5 kg [95% CI, 2.6-4.5} in the enhanc

134 At 6 months, the mean weight loss, relative to baseline, in the HF-F2F an

135 the amylin analog pramlintide elicited 12.7% mean weight loss, significantly more than was observed w

136 ot randomly assigned to this group (n = 294; mean weight loss: 0.8 kg).

137 rmal-weight, energy-balanced state (phase 4; mean weight loss: 12.9 +/- 2.0 kg).

138 ed to the weight-loss intervention (n = 291; mean weight loss: 4.4 kg) did not differ significantly f

139 Mean weight losses were 3.0 lb (1.36 kg) and 0.1 lb (0.0

140 with < or = 25% maximal cytoreduction had a mean weighted median survival time of 22.7 months, where

141 th more than 75% maximal cytoreduction had a mean weighted median survival time of 33.9 months--an in

142 adrenalectomy specimens was 28-297 g, with a mean weight of 122 g.

143 ared in neonatal (approximately 11 days old, mean weight of 24.5 g, mean volume of 25 cm3) and adult

144 had dilation at a mean age of 13 days and a mean weight of 3.4 kg.

145 5 cm3) and adult (approximately 80 days old, mean weight of 373.5 g, mean volume of 346 cm3) male Spr

146 For a patient population with a mean weight of 92 kg and no history of severe liver dise

147 Mean weight of each defecation and stool moisture did no

148 with either FGR (2 standard deviations below mean weight of nonchallenged dams) or normal weight.

149 After 4 weeks of treatment, the mean weight of primary tumors in animals receiving AN-23

150 Mean weights of fed ticks and percentage reaching replet

151 Mean weights of ingredients were calculated to obtain th

152 ant differences were found between groups in mean weight or body mass index-for-age z scores, waist c

153 Mean weighted overall percentages of NODM after DP for d

154 significantly older (P = .015), had a lower mean weight (P = .019), lower 25 hydroxy-vitamin D level

155 The mean weight percentile at closure was greater and the de

156 tnatal growth and development with a current mean weight percentile of 62+/-37 (median 80).

157 y significant increases from baseline in the mean weight percentiles were observed at years 1, 2, and

158 The mean weighted pretest probabilities of deep myometrial i

159 of catch and effort data for 23 species with mean weights ranging from 0.8 kg to 224 kg, recorded by

160 Primary outcome was mean weight regain at week 56.

161 Estimated mean weight regain was statistically significantly lower

162 lar between groups except for differences in mean weight (SD) (81 [17.3] vs. 76.3 [15.6]) and cumulat

163 Twelve swine (mean weight +/- SD, 38 +/- 5 kg) underwent percutaneous

164 nd significant CAV (stenosis >/=50%), showed mean weighted sensitivities of 97% and 94%, specificitie

165 gnostic accuracy significantly improved to a mean weighted sensitivity and specificity of 100% and 99

166 alysis of 64-slice CCTA versus IVUS showed a mean weighted sensitivity and specificity of 81% and 75%

167 ies provided data, permitting computation of mean-weighted sex differences in prevalence.

168 Cs were 47.6% lighter than the standard TCs (mean weight +/- standard deviation, 133 g +/- 14 vs 254

169 e of the height in meters) was 36.3, and the mean weight was 102.7 kg (225.9 lb).

170 ters) for all participants was 36.6, and the mean weight was 103.8 kg.

171 e of the patients was 45.1+/-12.0 years, the mean weight was 106.2+/-21.4 kg, and the mean BMI was 38

172 Mean weight was 117 +/- 23 kg (body mass index 48.3 +/-

173 Mean weight was 118 (range, 90-150) kg.

174 , mean BMI was 53.5 (95% CI, 52.9-54.0), and mean weight was 158.8 kg (95% CI, 155.3-162.3 kg).

175 y was 10.1+/-10.7 days (median, 8 days), and mean weight was 2.2+/-0.3 kg (median, 2.2 kg).

176 age at operation was 1.2 days (+/-1.1), the mean weight was 2.6 kg (+/-0.5), the mean operative time

177 Their mean weight was 20 kg.

178 Mean spleen size was 14 cm and mean weight was 263 g.

179 an age at repair was 16 +/- 13 days, and the mean weight was 3.2 +/- 0.7 kg.

180 , the age range was 1 month to 28 years, and mean weight was 37.7 kg +/- 33.1, with a range of 3.4-14

181 5.9 +/- 16.1 y for the whole population; the mean weight was 61.4 +/- 10.7 and 58.1 +/- 12.1 kg and b

182 termediate bilirubin concentrations and poor mean weight z-scores 3 months after HPE was also associa

183 Mean weight z-scores were significantly lower by 6 month